Circulating Tumor Cell Clinical Trials

51 clinical trials for Circulating Tumor Cell across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients — RECRUITING
• Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) — RECRUITING · NA
• CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial — RECRUITING · NA
• Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC — RECRUITING
• Using a 3D Culture Model for Circulating Tumor Cells Combined With Molecular Bioassays in Patients With HNSCC Cancer — RECRUITING
• Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery — RECRUITING · PHASE3
• ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer — RECRUITING · PHASE3
• Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA — RECRUITING · PHASE3
• Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer — RECRUITING · PHASE2
• EUS Guided HVA and PVA for Circulating Tumor DNA in Patients — RECRUITING · NA
• Open D3 Right Hemicolectomy Compared to Laparoscopic CME for Right Sided Colon Cancer — ACTIVE_NOT_RECRUITING · NA
• Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin — TERMINATED · NA
• Prospective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx) — COMPLETED
• Optimizing Endobronchial Ultrasound Sampling for Molecular Markers for NSCLC — ACTIVE_NOT_RECRUITING · NA
• CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood — ACTIVE_NOT_RECRUITING · NA
• CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC — NOT_YET_RECRUITING · PHASE1
• Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS — NOT_YET_RECRUITING
• The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC — OTHER
• Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer Surgery — COMPLETED · PHASE4
• Influence of Opioid Analgesia on Circulating Tumor Cells in Laparoscopic Colorectal Cancer Surgery — COMPLETED · PHASE4
• Liquid Biopsy for the Diagnosis of Intestinal-type Adenocarcinoma of the Ethmoid (BLADE) — OTHER · NA
• Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC — WITHDRAWN · PHASE2
• Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients — OTHER · NA
• Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients — OTHER · NA
• Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients — COMPLETED
• Circulating Tumor Cell Reducing No-touch Nephrectomy — COMPLETED · NA
• Impact of ctDNA in Cancer Early Detection and STAS Evaluation in Patients With GGOs — OTHER
• CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial — COMPLETED · NA
• Circulating Tumor Cell Detection in Hepatocellular Carcinoma — COMPLETED
• Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform — OTHER
• Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy — OTHER
• Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes — WITHDRAWN
• Feasibility of a New Technology for Isolating Circulating Tumour Cells — OTHER · NA
• Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs) — OTHER · PHASE2
• PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT — OTHER
• CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients — OTHER · PHASE3
• Treatment Response Prediction System of mCRC Patients Based on CTC — OTHER
• Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC — OTHER
• Circulating Tumor Cell Capture for Early Diagnosis and Postoperative Tumor Recurrence Monitoring of Liver Cancer — OTHER
• Circulating Tumour Cells in Patients With Peritoneal Metastases — COMPLETED
• Reduced Dissemination of Tumor Cells With Primary Ligation of the Vein in Patients With Lung Cancer — OTHER · NA
• WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC — OTHER · NA
• Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients — COMPLETED · NA
• Liquid Biopsy in Lung Cancer — COMPLETED
• Diagnostic Power Comparison Between VOCs and CTCs — OTHER
• Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology — OTHER
• Circulating Tumor Cells in mCRC for Liver Resection — OTHER
• MSI in Circulatory DNA of Endometrial Cancer — OTHER
• Sequence of Vessel Interruption and Circulating Tumor Cells in Surgical Lung Cancer — OTHER · NA
• CTC Detection Rate in SCCHN With a in Vivo Device — OTHER · NA

Refine this search